PMD Alliance is a 501c3 nonprofit organization dedicated to educating, empowering, and connecting people with movement disorders, their families, and the healthcare providers and community members who care for them.
Botulinumtoxins in the Management of Movement Disorders: Laxman Bahroo, DO
August 8th 2023The professor of neurology and residency program director at MedStar Georgetown University Hospital spoke to the evolution of the utility of botulinumtoxins in the treatment of patients with Parkinson and other movement disorders. [WATCH TIME: 4 minutes]
Patient-Centric, Knowledge-Driven: Advanced Therapeutics in Movement and Related Disorders™ Congress
July 14th 2023Clinicians must be armed with fact-based information on all treatment options especially newer medications and technologies—good clinical care must be both patient-centric and knowledge-driven.
Filling a Therapeutic Need in Parkinson Disease: Flexibility With IPX203
June 13th 2023Robert A. Hauser, MD, MBA, director of the Parkinson’s and Movement Disorders Center at the University of South Florida, provided insight on the therapeutic potential of IPX203, and why it adds flexibility to the treatment of Parkinson disease.
Extended-Release Amantadine Offers More Predictable Good ON Time for Those With Parkinson Disease
June 12th 2023Pooled results of a post hoc analysis from phase 3 studies of amantadine (Gocovri; Supernus) suggest that the therapy offers increased good ON time, and in intervals that are more predictable for patients, compared with placebo.
Increasing Utilization of Deep Brain Stimulation in Clinical Practice: Fiona Gupta, MD
June 12th 2023The assistant professor of neurology and director of the Movement Disorders Outreach Program at Mount Sinai Medical Center shed some light on the use of DBS in the clinic and how it has evolved as a therapeutic option for patients with Parkinson disease. [WATCH TIME: 2 minutes]
Patients With Parkinson Disease Might Benefit From Social Participation Education, Resources
June 10th 2023Data from an interventional survey suggest that patients with a better understanding of social participation’s benefits may be more confident to participate in social situations and events.
Survey Suggests Gaps in Communication With Parkinson Disease Care Partners
June 10th 2023A survey of more than 700 Parkinson disease caregivers highlighted the impact their role has on them emotionally, physically, and mentally, and pointed to several areas of need for support from the clinical community.
Care Access Challenges in Parkinson Disease and Movement Disorders: Fiona Gupta, MD
June 10th 2023The assistant professor of neurology and director of the Movement Disorders Outreach Program at Mount Sinai Medical Center spoke about the challenges with access to care in movement disorders. [WATCH TIME: 2 minutes]
The Expansion of Botulinumtoxin in the Clinical Care of Parkinson Disease: Laxman Bahroo, DO
June 10th 2023The professor of neurology and residency program director at MedStar Georgetown University Hospital discussed the value of educating clinicians on the utility of botulinumtoxins in PD care. [WATCH TIME: 3 minutes]
Ensuring Good Quality of Life With Good ON Time in Parkinson Disease: Khash Dashtipour, MD, PhD
June 9th 2023The director of the Movement Disorders Division at Loma Linda University discussed the importance of understanding good ON time in Parkinson disease care, and how it can influence quality of life. [WATCH TIME: 5 minutes]
Taking a Symptom-Based Approach to Parkinson Disease Psychosis: Aaron Ritter, MD
May 23rd 2023The director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute discussed the future of treating Parkinson disease psychosis, and potential ways to lower risk of poor long-term outcomes. [WATCH TIME: 3 minutes]
NeuroVoices: Aaron Ritter, MD, on Navigating Treatment Options for Parkinson Disease Psychosis
April 19th 2023The director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute provided detail on an educational course that examined medication management for Parkinson disease psychosis.
Learning From Patients and Looking to the Future of Movement Disorder Care
July 19th 2022Jill Farmer, DO, MPH, director of the Parkinson’s Disease and Movement Disorder Program at Global Neuroscience Institute, spoke at length about the recent ATMRD Congress, the state of care for movement disorders, and her hopes for the horizon of therapy and treatment.
The Need for More Time in Movement Disorder Care: Temitope Lawal, MD
July 19th 2022The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center spoke about the need for clinicians to have more time with patients in clinical practice, particularly with those with chronic diseases. [WATCH TIME: 2 minutes]
Drawing From Experience When Treating Parkinson Disease: Temitope Lawal, MD
July 14th 2022The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center spoke about how his experience as a caregiver shapes his perspective as a doctor in care for those with movement disorders. [WATCH TIME: 3 minutes]
Working With Interdisciplinary Teams in Movement Disorders: Temitope Lawal, MD
July 12th 2022The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center shared his experiences engaging with a diverse community of clinicians at the ATMRD Congress and in clinical practice. [WATCH TIME: 2 minutes]
Learning From Patients With Parkinson Disease: Laxman Bahroo, DO
July 6th 2022The assistant professor of neurology and codirector of the Neurology Residency Program at MedStar Georgetown University Hospital and presenter at ATMRD offered his insight into the benefits of multispecialty meetings. [WATCH TIME: 1 minute]
Reflecting on the Changes in Parkinson Disease and Movement Disorders Care
June 30th 2022Jean Hubble, MD, semi-retired neurologist and consultant, spoke with the PMD Alliance at the ATMRD Congress about the advances made in the field and her hopes for the future of therapeutics and clinical care.